Loading organizations...
Loading organizations...
Developer of small molecules targeting drug resistance in cancer therapy.
TOLREMO therapeutics has raised $54.9M across 4 funding rounds.
TOLREMO therapeutics has raised $54.9M in total across 4 funding rounds.
TOLREMO therapeutics has raised $54.9M in total across 4 funding rounds.
TOLREMO therapeutics's investors include BioMedPartners, Francesco Hofmann, Altos Ventures, Redalpine, Z%C3%BCrcher%20Kantonalbank, Andreas Wallnoefer.
TOLREMO therapeutics has raised $54.9M across 4 funding rounds. Most recently, it raised $38.0M Series A in September 2023.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Sep 20, 2023 | $38.0M Series A | BioMedPartners | Francesco Hofmann |
| Jun 10, 2020 | $5.0M Series A Extension | Altos Ventures, BioMedPartners | Redalpine, Z%C3%BCrcher%20Kantonalbank |
| Sep 24, 2018 | $9.4M Series A | Andreas Wallnoefer | Altos Ventures, Redalpine, Z%C3%BCrcher%20Kantonalbank |
| Sep 19, 2017 | $2.5M Other Equity |